Pubblicazioni

Aging and blood disorders: New perspectives, new challenges

2015 - HAEMATOLOGICA

Bron, D; Ades, L; Fulop, T; Goede, V; Stauder, R; Elderly Task Force in Hematology, EHA SWG; Foa, Roberto

PULMONARY INFECTIONS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RECEIVING AZACITIDINE TREATMENT

2015 - HAEMATOLOGICA

De Angelis, F; Latagliata, R; De Luca, Ml; Carmosino, I; Vozella, F; Petrucci, L; Colafigli, G; Mancini, M; Morano, Sg; Brunetti, G; Breccia, M; Alimena, G; Girmenia, C

PREDICTORS OF DEEP MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE: AN ANALYSIS BY THE GIMEMA CML WP

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Specchia, G; Binotto, G; Abruzzese, E; Iurlo, A; Vigneri, P; Cavazzini, F; Intermesoli, T; Ferrero, D; Martino, B; Leoni, P; Bocchia, M; Rege-Cambrin, G; Gherlinzoni, F; Bochicchio, Mt; Soverini, S; Alimena, G; Pane, F; Saglio, G; Cavo, M; Martinelli, G; Baccarani, M; Rosti, G

DEEP MOLECULAR RESPONSE TO NILOTINIB AS FIRST-LINE TREATMENT OF BCR-ABL plus CML

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Rossi, G; Stagno, F; Turri, D; Pregno, P; Tiribelli, M; Trabacchi, E; Carella, Am; Isidori, A; Pierri, I; Salvucci, M; Specchia, G; Levato, L; Avanzini, P; Bochicchio, Mt; Soverini, S; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G

A POPULATION-BASED STUDY OF MYELODYSPLASTIC SYNDROMES PATIENTS IN THE LAZIO REGION (ITALY), MISCODING IN MEDICAL CLAIMS AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

2015 - HAEMATOLOGICA

Mayer, F; Fenu, S; Agabiti, N; Buccisano, F; Latagliata, R; Ricci, R; Spiriti, Maa; Breccia, M; Cimino, G; Fianchi, L; Gumenyuk, S; Mancini, S; Maurillo, L; Nobile, C; Niscola, P; Piccioni, Al; Tafuri, A; Trape, G; Voso, Mt; Davoli, M; Zini, G

UNFAVORABLE KARYOTYPE AND MOLECULAR NEGATIVITY SIGNIFICANTLY INFLUENCE THE INFECTIOUS RISK IN MYELOFIBROSIS: EVALUATION ON 426 PATIENTS

2015 - HAEMATOLOGICA

Polverelli, N; Breccia, M; Benevolo, G; Latagliata, R; Catani, L; Perricone, M; Sollazzo, D; Colafigli, G; Nicolosi, M; Campana, A; Vitolo, U; Alimena, G; Martinelli, G; Cavo, M; Vianelli, N; Palandri, F

DASATINIB FIRST-LINE: UPDATE DI UNA ESPERIENZA "REAL-LIFE" ITALIANA

2015 - HAEMATOLOGICA

Breccia, M; Annunziata, M; Nardiello, I; Maggi, A; Sgherza, N; Russo-Rossi, A; Pregno, P; Castagnetti, F; Iurlo, A; Latagliata, R; Cedrone, M; Di Renzo, N; Sora, F; Rege-Cambrin, G; Caocci, G; Scortechini, Ar; Greco, G; Franceschini, L; Sica, S; Bocchia, M; Crugnola, M; Orlandi, E; Stagno, F; Luciano, L; Abruzzese, E; Rosti, G; Specchia, G; Guarini, A; Saglio, G; Alimena, G

INFECTIOUS RISK IN MYELOFIBROSIS: EVALUATION ON 426 PATIENTS

2015 - HAEMATOLOGICA

Polverelli, N; Breccia, M; Benevolo, G; Latagliata, R; Catani, L; Nicolosi, M; Perricone, M; Sollazzo, D; Romano, M; Colafigli, G; Forte, D; Campana, A; Testoni, N; Vitolo, U; Alimena, G; Martinelli, G; Cavo, M; Vianelli, N; Palandri, F

VERY ELDERLY CP-CML PATIENTS TREATED WITH IMATINIB FRONTLINE: HAVE CONCOMITANT THERAPIES AN IMPACT ON OUTCOME AND TOXICITY?

2015 - HAEMATOLOGICA

Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Fava, C; Annunziata, M; Stagno, F; Vigneri, P; Tiribelli, M; Cavazzini, F; Binotto, G; Mansueto, G; Gozzini, A; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Cattaneo, D; Djade, Cd; Cedrone, M; Rossi, Ar; Avanzini, P; Pregno, P; Mauro, E; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Sica, S; Storti, S; D'Addosio, A; Rege-Cambrin, G; Luciano, L; Saglio, G; Rosti, G; Alimena, G; Nobili, A; Cortelezzi, A

APPLICATION OF CARDIOVASCULAR RISK ASSESSMENT IN CHRONIC PHASE CML PATIENTS TREATED WITH NILOTINIB ALLOWS IDENTIFICATION OF SUBJECTS AT HIGH RISK OF EVENTS

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Quattrocchi, L; Saracino, R; Alimena, G

ACCURACY OF PHYSICIAN ASSESSMENT OF TREATMENT PREFERENCES AND HEALTH STATUS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES

2015 - HAEMATOLOGICA

Caocci, G; Voso, Mt; Angelucci, E; Stauder, R; Cottone, F; Abel, G; Nguyen, Ktt; Platzbecker, U; Beyne-Rauzy, O; Gaidano, G; Invernizzi, R; Molica, S; Criscuolo, M; Breccia, M; Lubbert, M; Sanpaolo, G; Buccisano, F; Ricco, A; Palumbo, G; Niscola, P; Zhang, H; Fenu, S; La Nasa, G; Mandelli, F; Efficace, F

PULMONARY INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES RECEIVING AZACYTIDINE TREATMENT

2015 - HAEMATOLOGICA

Latagliata, R; De Angelis, F; De Luca, Ml; Carmosino, I; Vozella, F; Montagna, C; Romano, A; Petrucci, L; Salaroli, A; Molica, M; Colafigli, G; Mancini, M; Breccia, M; Alimena, G; Girmenia, C

PROGNOSTIC FACTORS ASSOCIATED TO ACHIEVEMENT OF STABLE MR4.5 IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Molica, M; De Angelis, F; Quattrocchi, L; Latagliata, R; Mancini, M; Diverio, D; Alimena, G

LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FIRST-LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY

2015 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; Gozzini, A; Stagno, F; Rege-Cambrin, G; Carella, Am; Luciano, L; Specchia, G; Abruzzese, E; Martino, B; Usala, E; Rossi, G; Bocchia, M; Cavazzini, F; Tiribelli, M; Venturi, C; Soverini, S; Alimena, G; Cavo, M; Pane, F; Martinelli, G; Saglio, G; Rosti, G; Baccarani, M

A RETROSPECTIVE MULTICENTRE COMPARISON OF INTENSIVE CHEMOTHERAPY WITH AZACITIDINE FOR THE FRONT LINE TREATMENT OF ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS

2015 - HAEMATOLOGICA

Maurillo, L; Buccisano, F; Voso, Mt; Fianchi, L; Papayannidis, C; Gaidano, Gl; Breccia, M; Musto, R; Di Veroli, A; Martinelli, G; Lunghi, M; Lessi, F; Del Principe, Mi; Ramadan, Sm; Suciu, S; Amadori, S; Venditti, A

DEEP MOLECULAR RESPONSE TO NILOTINIB AS FIRST-LINE TREATMENT OF BCR-ABL plus CHRONIC MYELOID LEUKEMIA

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Rossi, G; Stagno, F; Turri, D; Pregno, P; Tiribelli, M; Trabacchi, E; Martino, B; Carella, Am; Isidori, A; Pierri, I; Salvucci, M; Specchia, G; Levato, L; Avanzini, P; Capalbo, S; Merli, A; Maino, E; Binotto, G; Bochicchio, Mt; Soverini, S; Cavo, M; Alimena, G; Martinelli, G; Saglio, G; Pane, F; Baccarani, M; Rosti, G

LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FRONTLINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY

2015 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; Gozzini, A; Stagno, F; Rege-Cambrin, G; Carella, Am; Luciano, L; Abruzzese, E; Martino, B; Usala, E; Rossi, G; Bocchia, M; Cavazzini, F; Tiribelli, M; Luatti, S; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Rosti, G; Baccarani, M

IS HIGH PLATELET COUNT AT DIAGNOSIS OF ESSENTIAL THROMBOCYTHEMIA A PROTECTIVE FACTOR FOR THROMBOSIS?

2015 - HAEMATOLOGICA

Andriani, A; Latagliata, R; Cedrone, M; Di Veroli, A; Spirito, F; Ruscio, C; Crescenzi, Sl; Porrini, R; Di Giandomenico, J; Villiva, N; Spadea, A; Rago, A; De Gregoris, C; Mastini, C; Anaclerico, B; De Muro, M; Felici, S; Breccia, M; Montefusco, E; Bagnato, A; Cimino, G; Majolino, I; Alimena, G; Montanaro, M

CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FIRST-LINE: AN ANALISYS OF THE GIMEMA CML WP

2015 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; Stagno, F; Martino, B; Fava, C; Luciano, L; Gozzini, A; Carella, Am; Abruzzese, E; Levato, L; Usala, E; Rossi, G; Bocchia, M; Tiribelli, M; Cavazzini, F; Salvucci, M; Cedrone, M; Trabacchi, E; Binotto, G; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G

LONG-TERM OUTCOME TO FIRST-LINE IMATINIB ACCORDING TO 2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA: A GIMEMA CML WP ANALYSIS

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; Iurlo, A; Albano, F; Abruzzese, E; Martino, B; Levato, L; Intermesoli, T; Pregno, P; Rossi, G; Gherlinzoni, F; Leoni, P; Cavazzini, F; Ferrero, D; Usala, E; Bocchia, M; Tiribelli, M; Montefusco, E; Sica, S; Venturi, C; Soverini, S; Cavo, M; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G

LONG TERM OUTCOME OF INTERMITTENT IMATINIB TREATMENT POLICY FOR MANAGING CHRONIC MYELOID LEUKEMIA IN THE ELDERLY

2015 - HAEMATOLOGICA

Russo, D; Malagola, M; Skert, C; Cancelli, V; Turri, D; Pregno, P; Pierri, I; Fogli, M; Testoni, N; De Vivo, A; Castagnetti, F; Pungolino, E; Stagno, F; Breccia, M; Martino, B; Intermesoli, T; Cambrin, Gr; Nicolini, G; Abruzzese, E; Tiribelli, M; Bigazzi, C; Usala, E; Russo, S; Russo-Rossi, A; Lunghi, M; Bocchia, M; D'Emilio, A; Santini, V; Girasoli, M; Di Lorenzo, R; Cesana, Bm; Soverini, S; Martinelli, G; Rosti, G; Baccarani, M

SMOOTHENED (SMO) INHIBITOR LDE225 COMBINED WITH NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT (R/I) TO AT LEAST 1 PRIOR TYROSINE KINASE INHIBITOR: A PHASE 1B STUDY

2015 - HAEMATOLOGICA

Ottmann, O; Charbonnier, A; Stegelmann, F; Breccia, M; Steegmann, Jl; Olavarria, E; Jevtic, S; Cota, M; Scheuer, N; Lipton, Jh

RECEIVER OPERATING CHARACTERISTIC ANALYSIS AS A TOOL TO IDENTIFY THRESHOLD VALUES OF CONTINOUS RISK FACTORS FOR THROMBOSIS AND SURVIVAL IN ESSENTIAL THROMBOCITEMIA: A RETROSPECTIVE ANALYSIS ON 1250 PATIENTS

2015 - HAEMATOLOGICA

Montanaro, M; Latagliata, R; Cedrone, M; Spirito, F; Ruscio, C; Crescenzi, Sl; Porrini, R; Di Giandomenico, J; Di Veroli, A; Villiva, N; Spadea, A; Rago, A; De Gregoris, C; Mastini, C; De Muro, M; Felici, S; Breccia, M; Montefusco, E; Bagnato, A; Anaclerico, B; Cimino, G; Majolino, I; Alimena, G; Andriani, A

SEX CORRELATED WITH DIFFERENCES IN LONG-TERM OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Molica, M; De Angelis, F; Quattrocchi, L; Latagliata, R; Mancini, M; Diverio, D; Alimena, G

EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS (TKIS)

2015 - HAEMATOLOGICA

Sora, F; Autore, F; Alimena, G; Annunziata, M; Avanzini, P; Bocchia, M; Breccia, M; Celesti, F; Chiusolo, P; Crugnola, M; Endri, M; Fava, C; Galimberti, S; Gozzini, A; Iurlo, A; Latagliata, R; Musto, P; Porrini, R; Pregno, R; Cambrin, Gr; Sica, S